Pier Capital’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Pier Capital’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-732,936	Closed	-$4.89M	–	139
2023 Q3	$4.89M	Sell	732,936 -146,233	-17%	-$1.22M	0.79%	68
2023 Q2	$7.97M	Buy	879,169 +16,433	+2%	+$145K	1.14%	44
2023 Q1	$6.27M	Buy	+862,736	New	+$6.4M	0.95%	54

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Pier Capital's PNT Position: Q4 2023 in Review

Pier Capital sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 732,936 shares — an estimated $4.89M sold.

Pier Capital first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $7.97M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Pier Capital reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Pier Capital sold 732,936 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $4.89M.
Pier Capital first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Pier Capital's POINT Biopharma Global Inc. Common Stock position peaked at $7.97M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.